DINUTUXIMAB

859 reported adverse events

Drug classes: Glycolipid Disialoganglioside-directed Antibody [EPC]

These side effects are most commonly reported by patients taking DINUTUXIMAB:

# Side effect Count
0 PYREXIA 172
1 OFF LABEL USE 116
2 PAIN 90
3 NEUROBLASTOMA RECURRENT 89
4 ABDOMINAL PAIN 80
5 VOMITING 68
6 ASPARTATE AMINOTRANSFERASE INCREASED 64
7 ALANINE AMINOTRANSFERASE INCREASED 62
8 HYPOTENSION 59
9 ANAEMIA 58
See all common reactions for DINUTUXIMAB

DINUTUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 18 0.6923
1 HUMAN ANTI-MOUSE ANTIBODY INCREASED 1 0.5000
2 CENTRAL NERVOUS SYSTEM NEUROBLASTOMA 1 0.5000
3 NEUROBLASTOMA RECURRENT 89 0.4384
4 PUPILLOTONIA 2 0.4000
5 RETRO-ORBITAL NEOPLASM 18 0.3396
6 KIDNEY HYPERMOBILITY 1 0.2000
7 THALAMIC MICROHAEMORRHAGE 1 0.1667
8 NEUROBLASTOMA 56 0.1462
9 PROTEIN ALBUMIN RATIO DECREASED 3 0.1364
See all enriched reactions for DINUTUXIMAB